Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca’s application (BLA) for durvalumab for BLA in bladder cancer was accepted by the FDA. The PD-L1 human monoclonal antibody…
OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter…
4D Pharma’s Blautix, a single strain live biotherapeutic for the treatment of chronic abdomen disorder, Irritable Bowel Syndrome (IBS), has…
The board of directors of Eli Lilly has announced a 2 percent increase in its quarterly dividend. The dividend for…
Shareowners of the Monsanto Company have approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft.
Zealand Pharma has on Monday increased its share capital with nominal DKK 13,999 divided into 13,999 new shares with a…
The results of Active Biotech’s rights issue show that 6,643,426 shares, which is about 96 percent of the shares offered,…
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Synjardy XR tablets for adults with type 2 diabetes.…
Bayer AG and Versant Ventures have announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to…
Alvogen on Monday launched the first flu capsules, generic equivalent to Roche’s Tamiflu (oseltamivir phosphate) capsules in the United States.